Literature DB >> 1653591

Acute non-immunological inflammation inhibits natural killer (NK) activity in the lungs and enhances metastatic development.

I Florentin1, D Nolibe, J P Giroud.   

Abstract

A non-immunological acute inflammatory reaction, induced in rats by intrapleural injection of calcium pyrophosphate microcrystals, decreased natural killer activity of lung intracapillary leucocytes (LICL), and, to a lesser extent, of spleen cells. NK activity was significantly depressed as early as 2 h after pleurisy induction, maximally suppressed at 72 h (when the inflammation had resolved) and returned to near-normal values by day 10. This decrease in NK activity was demonstrated using YAC-I lymphoma cells and syngeneic fibrohistiocytoma (P77) cells, as targets. The inhibition of NK activity of LICL was accompanied by an impaired destruction of P77 tumour cells injected i.v. 3 days after the onset of pleurisy. This was shown by an increase in the number of radiolabelled tumour cells surviving in the lungs at 24 h and of tumour nodules developed in lung parenchyma at 3 weeks. Suppression of NK activity was not due to a decrease in the proportion of large granular lymphocytes (LGL) in the LICL population. Suppressor macrophages may be involved, at least in part, since a partial restoration of LICL cytotoxicity was obtained after depletion of plastic-adherent cells. The effect of inflammation was reproduced in normal rats by injecting inflammatory serum or PGE2, suggesting a possible role of circulating mediators.

Entities:  

Mesh:

Year:  1991        PMID: 1653591      PMCID: PMC2002275     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  25 in total

1.  Inhibition of murine natural killer cell activity by prostaglandins.

Authors:  M J Brunda; R B Herberman; H T Holden
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

2.  Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.

Authors:  C H Ginsburg; J T Dambrauskas; K A Ault; Z M Falchuk
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

3.  The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.

Authors:  L A Holmberg; B A Miller; K A Ault
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

4.  Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo.

Authors:  N Hanna; R C Burton
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

5.  Natural killer funciton in systemic lupus erythematosus.

Authors:  T Hoffman
Journal:  Arthritis Rheum       Date:  1980-01

6.  Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.

Authors:  W E Seaman; T D Gindhart; M A Blackman; B Dalal; N Talal; Z Werb
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

7.  In vivo augmentation of rat lung natural killer cell activity and inhibition of experimental metastases by double-stranded polynucleotides.

Authors:  D Nolibe; E Aumaitre; M N Thang
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

8.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

9.  Free radical effects on membrane protein in myocardial ischemia/reperfusion injury.

Authors:  K J Kako
Journal:  J Mol Cell Cardiol       Date:  1987-02       Impact factor: 5.000

10.  Suppression of natural killer cytolytic activity in mice undergoing pulmonary granulomatous inflammation.

Authors:  D G Remick; S L Kunkel; G I Higashi; J C Hiserodt
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.